Cargando…
Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in Mycobacterium tuberculosis Infection and Disease
Eicosanoids modulate both innate and adaptive immune responses in Mycobacterium tuberculosis (Mtb) infection and have been suggested as possible Host Directed Therapy (HDT) targets, but more knowledge of eicosanoid dynamics in Mtb infection is required. We investigated the levels and ratios of eicos...
Autores principales: | Nore, Kristin Grotle, Jørgensen, Marthe Jøntvedt, Dyrhol-Riise, Anne Ma, Jenum, Synne, Tonby, Kristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693556/ https://www.ncbi.nlm.nih.gov/pubmed/33304347 http://dx.doi.org/10.3389/fimmu.2020.579849 |
Ejemplares similares
-
Monocytic myeloid‐derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase‐2 inhibitors
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020) -
Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2021) -
A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries
por: Chendi, Bih H., et al.
Publicado: (2021) -
Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice
por: Mortensen, Rasmus, et al.
Publicado: (2019) -
IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2015)